UPTRAVI (Actelion Pharmaceuticals US, Inc.)
Welcome to the PulseAid listing for the UPTRAVI drug offered from Actelion Pharmaceuticals US, Inc.. This Prostacyclin Receptor Agonist [EPC],Prostacyclin Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Actelion Pharmaceuticals US, Inc. |
| NON-PROPRIETARY NAME: | Selexipag |
| SUBSTANCE NAME: | SELEXIPAG |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Prostacyclin Receptor Agonist [EPC],Prostacyclin Receptor Agonists [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-12-21 |
| END MARKETING DATE: | 0000-00-00 |
UPTRAVI HUMAN PRESCRIPTION DRUG Details:
| Item Description | UPTRAVI from Actelion Pharmaceuticals US, Inc. |
| LABELER NAME: | Actelion Pharmaceuticals US, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200(ug/1) |
| START MARKETING DATE: | 2015-12-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 66215-602_74fb8ee2-0162-4b76-b542-1dacf580fb63 |
| PRODUCT NDC: | 66215-602 |
| APPLICATION NUMBER: | NDA207947 |
Other SELEXIPAG Pharmaceutical Manufacturers / Labelers:
